DalsnaFinance › IPOs › AN2 Therapeutics › IPO
AN2 Therapeutics, Inc. completed its initial public offering on NASDAQ on March 25, 2022, pricing at $15.00 a share.
| Ticker | ANTX |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | March 25, 2022 |
| Offering price | $15.00 |
| Shares offered | 4,600,000 |
| Total raised | $69M |
AN2 Therapeutics, Inc. sold 4,600,000 shares at $15.00 each on NASDAQ. Multiplied out, that is $69 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $69 million total recorded for the deal.
AN2 Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for AN2 Therapeutics, Inc.. This page is general information, not investment advice.